CoQ10 supplement for chronic pelvic pain in men
Part of Kidney & urinary, Pain clinical trials.
This trial tests whether a CoQ10 supplement (Ralivia) can reduce chronic pelvic or perineal pain lasting at least 3 months. The study aims to see if this supplement helps relieve symptoms when other treatments haven't fully worked.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old
- You have had pelvic or perineal pain or discomfort for at least 3 months in the past 6 months
- You have not had prostate, bladder, or urethral cancer
- You have not had pelvic radiation, chemotherapy, or recent pelvic surgery
- You do not have a urological implant (penile or urinary sphincter)
- You can understand the study requirements and agree to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at whether ozone therapy can help relieve chronic pelvic pain caused by gynecological cancer treatments like radiation and chemotherapy. It aims to understand how the treatment works at a molecular level.
This trial tests whether a natural supplement called CoQ10 (Ralivia) can help reduce urinary symptoms caused by an enlarged prostate. You'll take the supplement and have your symptoms monitored over time.
This trial tests if taking coenzyme Q10 before and after thoracoscopic lung surgery can reduce pain. It may help you recover more comfortably.
This study tests whether a drug called relugolix CT can reduce pelvic pain from endometriosis. You'll have brain scans and pain tests to measure how your body processes pain. It might help if other treatments haven't worked well.
This study tests whether Coenzyme Q10 (CoQ10) can help reduce fatigue and improve muscle strength in people who are taking GLP-1 medications for weight management. You will be asked to take a daily supplement (CoQ10 or placebo) for a period and track your progress via a smartphone app.
This trial tests if a non-invasive nerve stimulation device (TaVNS) can reduce pain, urinary symptoms, and mood issues in men with moderate to severe chronic pelvic pain syndrome (CP/CPPS). It may offer a new drug-free option for symptom relief.
Hear when a new Chronic Pelvic Pain Syndrome (CPPS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.